Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Giving Brands Company (GBCo) was an Australian personal care and wellness brand incubator and distributor that specialized in commercializing beauty and therapeutic products. The company's portfolio featured nailKALM, a clinically-proven, TGA-listed anti-fungal lotion containing the proprietary blue-green algae extract AMYCOT, alongside the Jbronze self-tanning line and the MICRO19 antibacterial sanitiser range. GBCo distributed its products through major pharmacy chains and retailers across Australia, New Zealand, and parts of Asia. Following severe retail disruptions during the COVID-19 pandemic, GBCo entered voluntary administration in March 2021 and was subsequently liquidated.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GBCo.